FAKTOR-OPTIONSSCHEIN - INMODE Share Price

Certificat

DE000MD0YM67

Market Closed - Bid/Ask 12:51:36 14/06/2024 am IST Pre-market 11:30:39 am
0.33 EUR -2.94% Intraday chart for FAKTOR-OPTIONSSCHEIN - INMODE 0.33 0.00%
1 month-5.71%
3 months-32.65%
Date Price Change
13/24/13 0.33 -2.94%
12/24/12 0.34 -2.86%
11/24/11 0.35 0.00%
10/24/10 0.35 +6.06%
07/24/07 0.33 0.00%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 12:51 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying INMODE LTD.
Issuer Morgan Stanley
WKN MD0YM6
ISINDE000MD0YM67
Date issued 06/01/2022
Strike 9.102 $
Maturity Unlimited
Parity 25.44 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.95
Lowest since issue 0.29
Spread 0.02
Spread %5.88%

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.2 USD
Average target price
25.6 USD
Spread / Average Target
+40.66%
Consensus